👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Raymond James lowers Walgreens Boots Alliance estimates

Published 08-06-2023, 11:46 pm
© Reuters.
WBA
-

Raymond James maintained a Market Perform rating on Walgreens Boots Alliance (NASDAQ:WBA) in a note Thursday, with analysts stating that they are cutting estimates ahead of the company's third-quarter earnings report.

However, the analysts noted that retail and U.S. health is unlikely to impact the company's guidance.

"We are lowering our F2023 Retail EBIT estimate by $143M to $4.16B due to lower assumed COVID earnings (-$150M vs. prior estimate), and 340B pressure (-$100M), while adding back ~$100M for increased RE sale-leaseback gains," explained the analysts.

"Our COVID assumption is now in-line with the CVS retail segment, where the latest guidance assumes COVID earnings decline ~75% y/y, along with a 340B cut of $100M ($200M annualized, or roughly 20% of estimated gross 340B gross profit)."

The analysts also said the firm is cutting its F2023 U.S. Health EBIT estimate for WBA "by $207M to ($467M) to account for a slower ramp in VillageMD/Summit Health earnings in F2H23 given the weak F1H23 trends and the sluggish Sept. 2022 quarterly Summit/City EBITDA of only $17M."

"We don't see the building blocks for the assumed back half ramp, given that all of the pieces were present in the Feb. quarter ex-1 month of Summit/City," they concluded.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.